Res Clin
Gastroenterol., 31: 637-42 (2017).
3. Zhang T., et al., Microb Biotechnol., 12:
1109-125 (2019).
4. Belzer C. and de Vos WM., ISME J., 6:
1449–58 (2012).
5. Png CW., et al., Am
Duuren, B.L., et al., Chem.-Biol. Interactions, vol. 15, 236 (1976).
5. Hecker, E. and Schmidt, R., Progr. Org. Nat. Prod., vol. 31, 377-468 (1974).
6. Schmidt, R. and Hecker, E., Cancer Research, vol
diluted in buffer (B) to obtain standard
solutions at the following concentrations: 500, 250,
125, 63, 31, and 15 pg/0.1 ml.
B. Dilution buffer: 0.01 M phosphate buffered saline,
pH 7.4 containing
diluted in buffer (B) to obtain standard solutions at
the following concentrations: 500, 250, 125, 63, 31,
and 15 pg/0.1 ml.
B. Dilution buffer: 0.01 M phosphate buffered saline,
pH 7.4 containing
only at much
higher concentrations (IC50 = 6.1 µM, 125 µM,
and > 10 µM for PKC-α, PKA, and EGFR,
respectively). Purity: ≥97% by HPLC.
Cat. No. 217696 5 mg
Ref.: Yu. C., et al. 2003. Cancer Res. 63, 1822
further diluted in
buffer (B) to obtain standard solutions at the fol-
lowing concentrations: 250, 125, 63, 31 and 15
pg/0.1 ml.
(B) Dilution buffer: 0.05 M Tris-HCl (Sigma Product
No. T-3523), pH 8.0
solutions at the following concentra-
add 5.0 ml of 0.01 M sodium phosphate buffered tions: 500, 250, 125, 63, 31, and 15 pg/0.1 ml.
saline, pH 7.4, containing 0.1% BSA and 0.1% (B) Dilution buffer: 0.01 M phosphate
or 4) of microtubule
binding repeats (R) of 31–32 amino acids each, and the
number (0, 1, or 2) of amino terminal inserts (N) of
29 amino acids each.
5
The six isoforms are
designated:
publication reports preparation of 125 units/mL stock
solutions of this product in 10 mM HEPES (pH 7.8).16
Storage/Stability
• Stock solutions at pH between 5-7.5 can be
stored as frozen aliquots
endcapped 1.50255.0001 5 µm 125 mm 2 mm 1 piece
Purospher® STAR RP-18 endcapped 1.50256.0001 5 µm 250 mm 2 mm 1 piece
Purospher® STAR RP-18 endcapped 1.50253.0001 5 µm 125 mm 3 mm 1 piece
Purospher
197 (2002).
5. Ringel, F., et al., Contribution of anion transporters
to the acidosis-induced swelling and intracellular
acidification of glial cells. J. Neurochem., 75(1),
125-132 (2000).
at room temperature for 30 minutes.
4. Add 0.05 ml of I-oxytocin solution (C) (1-2 pg/ml)125
to each tube.
5. Prepare two empty tubes to the total count (T). Add
0.05 ml I-oxytocin solution (C)
Neutralization Dose50 (ND50) for Anti-FGF-7 is
~ 6-12 µg/mL in the presence of 125 ng/mL of
recombinant human FGF-7 using the 4MBr-5 cell line.
The ND50 is the concentration of antibody required to
yield
Biochemistry, 31, 3103-12 (1992).
5. Howden, R. et al., Selection of T-DNA-tagged male
and female gametophytic mutants by segregation
distortion in Arabidopsis., Genetics, 149, 621-31
(1998).
6
Biochemistry, 31, 3103-12 (1992).
5. Howden, R. et al., Selection of T-DNA-tagged male
and female gametophytic mutants by segregation
distortion in Arabidopsis., Genetics, 149, 621-31
(1998).
6
Biochemistry, 31, 3103-12 (1992).
5. Howden, R. et al., Selection of T-DNA-tagged male
and female gametophytic mutants by segregation
distortion in Arabidopsis., Genetics, 149, 621-31
(1998).
6
vemurafenib and dabrafenib,
were purchased from Selleckchem. Cells were treated with 2 µM
vemurafenib or 125 nM dabrafenib for 72 hours, with fresh
culture media replenished every 24 hours. Culture dishes were
diluted in buffer (B) to
obtain standard solutions at the following
concentrations: 500, 250, 125, 63, 31, 15, 8, and
4 pg/0.1 ml.
(B) Dilution buffer: 0.05 M
± 0,5 2-15 mg/ml 24 meses
125 ml a granel
1 litro a granel
10 litros a granel
KC-125ML-BK
KC-1L-BK
KC-10L-BK
Anti-E IgM humana MS-260 7,2 ± 0,5 5-16 mg/ml 24 meses
125 ml a granel
1 litro a granel